FZD9 and non-small cell lung carcinoma: Via activating JNK pathway, Wnt-7a and Fzd-9 signaling plays role in inducing the receptor tyrosine kinase inhibitor Sprouty-4 and cadherin proteins and is essential for maintaining epithelial differentiation and inhibiting transformed cell growth in some NSCLC patients [31].